GLP-1, glucagon-like peptide-1
This provided an ideal setting to begin his hunt for the putative GIP
Key Takeaways Up to 1 in 5 people using GLP-1 medications develop nutritional deficiencies within 12 months , with vitamin D and calcium most commonly affected Appetite suppression often results in low protein intake , increasing the risk of muscle loss during peri-menopause Standard multivitamins are rarely sufficient to meet calcium and vitamin D requirements Resistance training and personalised nutrition planning are essential to protect muscle mass and bone density GLP-1 Summary The Promise and the Paradox of GLP-1 Medications GLP-1 medications work by slowing gastric emptying and reducing appetite
In GLP-1-infused subjects, plasma levels of GLP-1 rose from ~ 19 pM to 197 pM by week 1, and 282 pM at week 6
As of now, retatrutide is NOT approved for human use
With weekly injections, you can expect gradual and sustained appetite suppression, which helps reduce calorie intake and makes it easier to maintain healthier eating habits
